TREM2 and Alzheimer disease: Genome-wide association studies (GWAS) and meta-analysis have found immunogenetic variants associated with AD, namely CR1, CLU, TREM2, PICALM, CD33, and MEF2C, reasserting the role of the immune system in AD pathophysiology [13–17].